In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, became the recipient of a human kidney. A new Mass General Brigham paper, published in The Lancet, details Andrews' experience and how xenotransplantation could bridge the gap between end-stage kidney failure and a human transplant, allowing a patient to forgo dialysis in the meantime.
Successful Pig Kidney Xenotransplant Paves Way for Human Transplant in End-Stage Kidney Disease Patient
In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, successfully transitioned to a human kidney transplant. This case highlights the potential of xenotransplantation to address organ shortages and improve patient outcomes. For Iran, advancements in medical technology like xenotransplantation could influence healthcare policies and organ donation practices.
👥 Key Players
📰 What Happened
Tim Andrews successfully transitioned from a genetically edited pig kidney to a human kidney transplant, showcasing the potential of xenotransplantation as a temporary solution for patients awaiting human organ transplants.
- The pig kidney was genetically edited to reduce rejection risk.
- This case could help bridge the gap in organ shortages for patients with end-stage kidney disease.
💡 Why It Matters
📚 Background
Xenotransplantation involves using animal organs for human transplants, which could alleviate the shortage of human organs for transplantation.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%